论文部分内容阅读
目的:探究小儿肺热咳喘颗粒治疗上呼吸道感染的临床价值。方法:选择2015年3月-2016年3月我院收治的50例上呼吸道感染小儿患者为研究对象,将其分成两组,对照组行常规治疗方式,以此为基础,观察组使用小儿肺热咳喘颗粒进行治疗,治疗结束后,对患者的治疗结果,临床症状消失时长进行全面评价。结果:和对照组相比,观察组患者无论是在治疗有效率与临床症状消失时长方面,均较好,组间数据存在统计学差异,P<0.05。结论:对于上呼吸道感染患儿,以常规治疗为基础,使用小儿肺热咳喘颗粒进行治疗,安全性高,临床效果好,值得进一步推广使用。
Objective: To investigate the clinical value of pediatric Feirecukechuan granule in the treatment of upper respiratory tract infection. Methods: From March 2015 to March 2016, 50 cases of pediatric patients with upper respiratory tract infection admitted to our hospital were selected as study subjects and divided into two groups. The control group received routine treatment. Based on this, the observation group used pediatric lung Heat cough particles for treatment, the treatment is completed, the patient’s treatment results, the clinical symptoms disappeared for a comprehensive evaluation. Results: Compared with the control group, the observation group patients were both good in the treatment efficiency and the disappearance of the clinical symptoms, with statistical differences between the two groups (P <0.05). Conclusion: For children with upper respiratory tract infection, based on routine treatment, the use of Hyperactivity-Kechuan Granule in children is safe and has good clinical effect. It is worth further promotion and use.